This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
PD15 ‐ MP29‐02 effectively relieves both nasal and ocular symptoms in adolescents aged 12‐17 years: results from a meta‐analysis of 4 randomised controlled Seasonal Allergic Rhinitis (SAR) trials. (28th February 2014)
Record Type:
Journal Article
Title:
PD15 ‐ MP29‐02 effectively relieves both nasal and ocular symptoms in adolescents aged 12‐17 years: results from a meta‐analysis of 4 randomised controlled Seasonal Allergic Rhinitis (SAR) trials. (28th February 2014)
Main Title:
PD15 ‐ MP29‐02 effectively relieves both nasal and ocular symptoms in adolescents aged 12‐17 years: results from a meta‐analysis of 4 randomised controlled Seasonal Allergic Rhinitis (SAR) trials